Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03462740

Ligand	Ligand name	Chain	PDB	Tanimoto
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.75
114	COMPACTIN	A,B,C,D	1HW8	0.75
TES	TESTOSTERONE	A	1JTV	0.7
TES	TESTOSTERONE	A	2Q7L	0.7
TES	TESTOSTERONE	A	2Q7I	0.7
TES	TESTOSTERONE	A,B	1J96	0.7
TES	TESTOSTERONE	A	2Q7K	0.7
TES	TESTOSTERONE	A,B	1Q13	0.7
TES	TESTOSTERONE	H	1I9J	0.7
TES	TESTOSTERONE	A,B	1AFS	0.7
TES	TESTOSTERONE	H	1VPO	0.7
TES	TESTOSTERONE	A	2Q7J	0.7
TES	TESTOSTERONE	A,B	3BUR	0.7
TES	TESTOSTERONE	A	2AM9	0.7
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.71
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.72
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.73
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.78
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	2GZ5	0.73
OVA	3,4-DIHYDROXY-2-METHOXY-4-METHYL-3-[2-METHYL-3-(3-METHYL-BUT-2-ENYL) -OXIRANYL]-CYCLOHEXANONE	A	1B59	0.73
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.76
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.7
VTQ	RRR-ALPHA-TOCOPHERYLQUINONE	A,C,E	1OLM	0.71
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.7
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.7
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.7
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.7
HYF	4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE	A	1M13	0.78
C0R	CORTICOSTERONE	A	2A3I	0.72
C0R	CORTICOSTERONE	A,B	1Y5R	0.72
803	LOVASTATIN	A,B	1CQP	0.71
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.7
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.73
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.7
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.72
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.72
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.72
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.72